share_log

Chimerix | 8-K: Current report

Chimerix | 8-K: Current report

Chimerix | 8-K：重大事件
美股SEC公告 ·  2024/06/22 04:09

Moomoo AI 已提取核心信息

At Chimerix's 2024 Annual Meeting held on June 20, shareholders elected three Class II directors - Martha J. Demski, Pratik S. Multani, and Vicki Vakiener - to serve until 2027. The meeting saw participation from 61.67 million shares out of 89.63 million outstanding shares.Shareholders approved key proposals including the 2024 Equity Incentive Plan, ratified Ernst & Young LLP as the independent auditor for FY2024, and endorsed the compensation of named executive officers on an advisory basis. The voting results showed strong support, with the director nominees receiving between 38.2 and 39.5 million favorable votes.In a separate development, the Board appointed Marc D. Kozin to the Audit Committee, joining Fred A. Middleton and Martha J. Demski, following Patrick Machado's previous resignation.
At Chimerix's 2024 Annual Meeting held on June 20, shareholders elected three Class II directors - Martha J. Demski, Pratik S. Multani, and Vicki Vakiener - to serve until 2027. The meeting saw participation from 61.67 million shares out of 89.63 million outstanding shares.Shareholders approved key proposals including the 2024 Equity Incentive Plan, ratified Ernst & Young LLP as the independent auditor for FY2024, and endorsed the compensation of named executive officers on an advisory basis. The voting results showed strong support, with the director nominees receiving between 38.2 and 39.5 million favorable votes.In a separate development, the Board appointed Marc D. Kozin to the Audit Committee, joining Fred A. Middleton and Martha J. Demski, following Patrick Machado's previous resignation.
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    ImmunoPrecise Antibodies
    IPA
    -- 0.747
    Nutriband
    NTRB
    -- 6.845
    Metagenomi Technologies, LLC
    MGX
    -- 3.350
    Cardio Diagnostics
    CDIO
    -- 0.700
    Anixa Biosciences
    ANIX
    -- 3.115
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球股市新风口在哪里？
    ▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？ 展开
    离川普上台只有7天了～
    热门中概股
    追踪最热门的中概股实时资讯。